合計 50 件の最近のインサイダー取引記録が記録されています Catalyst Pharmaceuticals, Inc. (CPRX), 内訳は 19 件の買い および 29 件の売り. インサイダー買い総額は $21.97M インサイダー売り総額は $15.41M.
最近活動のある主要インサイダーには Russo Gregg, Daly Richard J, Kalb Michael Wayne. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — CPRX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-02-17 |
Russo Gregg |
Chief HR Officer |
RSU 源泉徴収 |
211 |
- |
- |
476 |
| 2026-01-05 |
Daly Richard J |
President and CEO |
RSU 源泉徴収 |
10,577 |
- |
- |
271,266 |
| 2026-01-05 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU 源泉徴収 |
2,080 |
- |
- |
13,665 |
| 2025-12-29 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
オプション行使（売却） |
26,334 |
- |
- |
1,851,948 |
| 2025-12-29 |
Denkhaus Donald A |
Director |
オプション行使（売却） |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Tierney David S |
Director |
オプション行使（売却） |
1,334 |
- |
- |
178,163 |
| 2025-12-29 |
Miller Steve |
Chief Op. & Scientific Officer |
オプション行使 |
14,000 |
- |
- |
1,093,803 |
| 2025-12-29 |
Daly Richard J |
President and CEO |
RSU 源泉徴収 |
524 |
- |
- |
239,738 |
| 2025-12-29 |
Elsbernd Brian |
Chief Compliance/legal Officer |
RSU 源泉徴収 |
2,623 |
- |
- |
242,501 |
| 2025-12-29 |
Del Carmen Jeffrey |
Chief Commercial Officer |
RSU 源泉徴収 |
3,839 |
- |
- |
14,337 |
| 2025-12-29 |
Harper Molly |
Director |
オプション行使 |
1,334 |
- |
- |
3,694 |
| 2025-12-29 |
Sundaram Preethi |
Chief Strategy Officer |
RSU 源泉徴収 |
2,369 |
- |
- |
54,804 |
| 2025-12-12 |
Harper Molly |
Director |
情報に基づく売り |
6,746 |
$23.06 |
$155.56K |
2,360 |
| 2025-12-08 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
オプション行使（売却） |
3,534 |
- |
- |
1,878,282 |
| 2025-12-08 |
Denkhaus Donald A |
Director |
オプション行使（売却） |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Tierney David S |
Director |
オプション行使（売却） |
1,413 |
- |
- |
179,497 |
| 2025-12-08 |
Miller Steve |
Chief Op. & Scientific Officer |
オプション行使 |
11,873 |
- |
- |
1,079,803 |
| 2025-12-08 |
Elsbernd Brian |
Chief Compliance/legal Officer |
RSU 源泉徴収 |
2,780 |
- |
- |
238,457 |
| 2025-12-08 |
Del Carmen Jeffrey |
Chief Commercial Officer |
RSU 源泉徴収 |
2,492 |
- |
- |
9,509 |
| 2025-12-08 |
Thompson Tamar |
Director |
オプション行使 |
1,413 |
- |
- |
3,773 |
| 2025-12-08 |
Harper Molly |
Director |
オプション行使 |
1,413 |
- |
- |
9,106 |
| 2025-12-08 |
Sundaram Preethi |
Chief Strategy Officer |
RSU 源泉徴収 |
1,669 |
- |
- |
50,506 |
| 2025-12-01 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
贈与（送付） |
45,000 |
- |
- |
4,148,477 |
| 2025-11-26 |
Del Carmen Jeffrey |
Chief Commercial Officer |
情報に基づく売り |
10,983 |
$23.33 |
$256.24K |
3,962 |
| 2025-11-21 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
オプション行使（売却） |
1,775 |
- |
- |
1,881,816 |
| 2025-11-21 |
Tierney David S |
Director |
オプション行使（売却） |
947 |
- |
- |
180,910 |
| 2025-11-21 |
Miller Steve |
Chief Op. & Scientific Officer |
オプション行使 |
8,267 |
- |
- |
1,067,930 |
| 2025-11-21 |
Daly Richard J |
President and CEO |
オプション行使 |
20,006 |
- |
- |
246,800 |
| 2025-11-21 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU 源泉徴収 |
2,485 |
- |
- |
8,606 |
| 2025-11-21 |
Thompson Tamar |
Director |
オプション行使 |
947 |
- |
- |
2,360 |
| 2025-11-21 |
Harper Molly |
Director |
オプション行使 |
947 |
- |
- |
7,693 |
| 2025-11-21 |
Sundaram Preethi |
Chief Strategy Officer |
RSU 源泉徴収 |
1,364 |
- |
- |
45,320 |
| 2025-11-20 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
RSU 付与（制限付株式） |
34,921 |
$22.77 |
$795.15K |
1,873,051 |
| 2025-11-20 |
Tierney David S |
Director |
RSU 付与（制限付株式） |
18,115 |
$22.77 |
$412.48K |
176,389 |
| 2025-11-20 |
Miller Steve |
Chief Op. & Scientific Officer |
RSU 付与（制限付株式） |
158,454 |
$22.77 |
$3.61M |
1,457,963 |
| 2025-11-20 |
Daly Richard J |
President and CEO |
RSU 付与（制限付株式） |
381,948 |
$22.77 |
$8.7M |
2,546,695 |
| 2025-11-20 |
Kalb Michael Wayne |
Executive Vice President & CFO |
RSU 付与（制限付株式） |
131,536 |
$22.77 |
$3M |
607,235 |
| 2025-11-20 |
Thompson Tamar |
Director |
RSU 付与（制限付株式） |
18,115 |
$22.77 |
$412.48K |
116,555 |
| 2025-11-20 |
Harper Molly |
Director |
RSU 付与（制限付株式） |
18,115 |
$22.77 |
$412.48K |
145,389 |
| 2025-11-20 |
Sundaram Preethi |
Chief Strategy Officer |
RSU 付与（制限付株式） |
106,873 |
$22.77 |
$2.43M |
785,305 |
| 2025-11-20 |
Russo Gregg |
Chief HR Officer |
RSU 付与（制限付株式） |
20,531 |
$22.77 |
$467.49K |
66,276 |
| 2025-06-11 |
Sundaram Preethi |
Chief Strategy Officer |
情報に基づく売り |
1,600 |
$26.42 |
$42.27K |
41,081 |
| 2025-06-10 |
Sundaram Preethi |
Chief Strategy Officer |
情報に基づく売り |
2,324 |
$26.41 |
$61.38K |
42,681 |
| 2025-06-09 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
情報に基づく売り |
171,748 |
$26.11 |
$4.48M |
4,281,702 |
| 2025-06-06 |
Mcenany Patrick J |
Other: Chairman of Board of Directors |
情報に基づく売り |
28,252 |
$25.95 |
$733K |
4,453,450 |
| 2025-06-02 |
Andrews William T. |
Chief Medical Officer |
不明 |
15,261 |
- |
- |
- |
| 2025-05-30 |
Daly Richard J |
President and CEO |
情報に基づく買い |
70,000 |
$24.86 |
$1.74M |
199,764 |
| 2025-05-14 |
Ingenito Gary |
Chief Med. & Reg. Officer |
情報に基づく売り |
44,000 |
$23.63 |
$1.04M |
68,873 |
| 2025-05-13 |
Ingenito Gary |
Chief Med. & Reg. Officer |
情報に基づく売り |
200,000 |
$23.68 |
$4.74M |
68,873 |
| 2025-03-06 |
Ingenito Gary |
Chief Med. & Reg. Officer |
情報に基づく売り |
180,096 |
$21.67 |
$3.9M |
68,873 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
